Glomerular Diseases, Autoimmunity & Immune Kidney Disorders

Glomerular diseases such as lupus nephritis, IgA nephropathy, membranous nephropathy, and ANCA-associated vasculitis involve complex immune dysregulation. Advances in immunopathology help decode complement activation pathways, autoantibody profiles, and inflammatory mediators driving glomerular damage. Targeted biologics, complement inhibitors, and B-cell modulation therapies reduce disease activity with fewer systemic side effects. Molecular diagnostics and renal biopsy biomarkers improve disease classification, allowing early treatment decisions that prevent irreversible scarring. Personalized immunotherapy is emerging as a major breakthrough in improving long-term renal outcomes.

    Related Conference of Glomerular Diseases, Autoimmunity & Immune Kidney Disorders

    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    April 27-28, 2026

    11th World Kidney Congress

    London, UK
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France
    August 27-28, 2026

    30th European Nephrology Conference

    Berlin, Germany
    November 10-11, 2026

    13th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands

    Glomerular Diseases, Autoimmunity & Immune Kidney Disorders Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in